Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

A testosterone patch improves sexual functioning in postmenopausal women with HSDD

Oct. 22, 2004

Nonsteroidal SARM shows potential for osteoporosis

Oct. 22, 2004

One-year results of the MOBILE study on ibandronate in osteoporosis

Oct. 22, 2004

Roche signs for rights to Japan Tobacco's CETP inhibitor JTT-705

Oct. 22, 2004

New melanocortin MC4 receptor ligands and their use reported by SCRAS

Oct. 22, 2004

Two series of SERMs claimed by Merck scientists

Oct. 22, 2004

Bio-E-Gel shows efficacy in the management of vasomotor symptoms after menopause

Oct. 22, 2004

IL-8 inhibition with statins a possible therapy for endometriosis

Oct. 21, 2004

Erectile dysfunction treatment with tadalafil extensively studied

Oct. 21, 2004

Pharmacokinetics and safety profile of bazedoxifene in Chinese women

Oct. 21, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
Roche reports new TREM2 agonists
BioWorld Science
F. Hoffmann-la Roche Ltd. and Hoffmann-La Roche Inc. have identified new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for...
Genescience presents STAT6 degrader for atopic dermatitis
BioWorld Science
Genescience Pharmaceutical Co. Ltd. has presented data on a new STAT6 PROTAC degrader – GenSciP166 – which selectively targets STAT6 for proteasomal degradation....
Recludix’s first-in-class STAT6 inhibitor shows efficacy in atopic dermatitis
BioWorld Science
Researchers from Recludix Pharma Inc. reported preclinical efficacy data on REX-8756 (SAR-448755), a first-in-class orthosteric STAT6 inhibitor in models of...